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Background:  This study evaluated the efficacy of a T-wave change after the IV administration of low dose 
epinephrine containing the test dose during spinal anesthesia. 
Methods:  Eighty healthy adults undergoing spinal anesthesia were enrolled in this study.  The subjects were divided 
randomly into the following 4 groups: Group S (n = 20) received 3 ml of normal saline, group L (n = 20) received 
3 ml of 1.0% lidocaine, group E5 received 3 ml of 1.0% lidocaine with epinephrine 5 μg, and group E10 received 3 
ml of 1.0% lidocaine with epinephrine 10 μg.  The heart rate (HR) and T-wave amplitude were measured with an 
electrocardiogram and systolic blood pressure (SBP) using a non-invasive method.  Positive responses were defined 
as an increase in HR ≥ 20 bpm or SBP ≥ 15 mmHg, or a decrease in the T-wave amplitude ≥ 25%.
Results:  The sensitivity (Ss), specificity (Sp), positive predictive value (PPV), and negative predictive value (NPV) of 
the HR increases were 80%, 100%, 100%, and 83%, respectively, in groups E5 and E10.  For the SBP increases, the Ss, 
Sp, PPV, and NPV were respectively, 55%, 100%, 100%, and 70% in group E5, and 80%, 100%, 100%, and 83% in group 
E10.  For the ≥ 25% decrease in T-wave amplitude, Ss, Sp, PPV, and NPV were respectively, 100%, 90%, 91%, and 100% 
in group E5, and 95%, 90%, 90%, and 95% in group E10.
Conclusions:  These results suggest that a change in the T-wave amplitude is useful for detecting the unintentional IV 
administration of low dose epinephrine during CSEA.  (Korean J Anesthesiol 2010; 58: 351-356)
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The change of T-wave on electrocardiogram after 
epinephrine test dose in spinal anesthetized adults
Jeong Woo Lee, Deokyu Kim, Hyun Ho Choi, and Dong Chan Kim
Department of Anesthesiology and Pain Medicine, Chonbuk National University Medical School, Jeonju, Korea
Received: December 1, 2009.  Revised: 1st, December 26, 2009; 2nd, January 26, 2010.  Accepted: February 22, 2010.
Corresponding author: Dong Chan Kim, M.D., Ph.D., Department of Anesthesiology and Pain Medicine, Chonbuk National University Medical 
School, 634-18, Geumam-dong, Deokjin-gu, Jeonju 561-712, Korea. Tel: 82-63-250-1241, Fax: 82-63-250-1240, E-mail: dckim@chonbuk.ac.kr
    This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, 
provided the original work is properly cited.
CC352 www.ekja.org
T-wave change after epinephrine dose Vol. 58, No. 4, April 2010
Introduction
    Combined spinal and epidural anesthesia (CSEA) is a regional 
anesthetic technique that combines the benefits of both spinal 
and epidural anesthesia. The spinal component provides the 
rapid onset of a predictable block. The indwelling epidural 
catheter allows the dose to be titrated to the desired neuroaxial 
block effect and provide long lasting analgesia [1]. Because 
of these potential advantages, CSEA is a useful anesthetic 
technique for Caesarean sections. 
    However, during CSEA, confirmation of the correct position 
of the indwelling epidural catheter before the administration 
of a large quantity of local anesthetic is very important for 
avoiding life-threatening complications due to intrathecal or 
intravascular injection of a large quantity of a local anesthetic. 
To confirm the correct position of the indwelling epidural 
catheter, a small quantity of a local anesthetic and epinephrine 
mixture, 'epidural test dose' is administered through an 
indwelling epidural catheter. The position of the indwelling 
epidural catheter is then evaluated by observing the patient’s 
response [2]. In 1981, Moore and Batra [3] first demonstrated the 
clinical value of a mixture of lidocaine 45 mg and epinephrine 
15 μg as the epidural test dose, which is currently used widely as 
an epidural test dose.
    Recently it was reported that the intravascular injection of 
simulated epidural test doses containing epinephrine results 
in a change in the T-wave on an electrocardiogram (ECG) [4-8]. 
In addition, Tanaka et al. [7] reported that the change in T-wave 
on ECG was induced by a lower dose of epinephrine than the 
traditional test dose (15 μg). The results of these studies suggest 
that the incidental intravascular injection of an epinephrine-
containing test dose can be detected by observing the change 
in the T-wave on ECG. Although the results of these studies 
were obtained on non-anesthetic patients or general anesthetic 
patients, it may be inappropriate to apply these to spinal 
anesthetic patients.
    Therefore, this study evaluated the change in T-wave on ECG 
after the intravascular administration of a lower dose epin-
ephrine-containing epidural test dose during spinal anesthesia.
Materials and Methods 
    This study was approved by the Hospital Ethics Committee 
and informed consent from all participating patients was 
obtained. The subjects were 80 ASA PS I patients, aged 18-
65 years. The patients were scheduled to undergo spinal 
anesthesia for elective surgery. None of the patients were 
taking cardiovascular drugs. The patients were divided into four 
groups in a randomized and double-blind manner. Group S (n 
= 20) received 3 ml of normal saline. Group L (n = 20) received 
3 ml of 1.0% lidocaine. Group E5 (n = 20) received 3 ml of 1.0% 
lidocaine with epinephrine 5 μg. Group E10 (n = 20) received 
3 ml of 1.0% lidocaine with epinephrine 10 μg. Table 1 lists the 
demographic data and sensory block levels.
    All patients arrived at the operating room without preme-
dication. The patients were monitored with ECG using five 
electrodes, noninvasive blood pressure, and the peripheral 
saturation of pulse oxymetry. The administration route of the 
test dose was limited to the forearm veins in all patients. In the 
case of patients with the IV line in another part of the body, the 
IV route was secured on the forearm vein. All patients under  -
went spinal anesthesia with hyperbaric bupivacaine 10-15 
mg via a 25-gauge Quincke needle inserted at the L3-4 or L4-5 
interspace. The SBP and HR were monitored every 1 minute for 
the first 10 minutes and every 5 minute until the experi  ment was 
started. While monitoring the SBP and HR, the patients received 
8 ml/kg of Ringer's lactate solution. None of the patients 
required a vasopressor agent because the SBP was reduced to 
<80 mmHg before starting the experiment of the simulating 
IV test dose. The level of block was confirmed by a cold test 
and pinprick test at 5 and 30 minutes after the intrathecal 
administration of local anesthetics.
    After confirming the block level in the first 30 minutes, the 
baseline of the SBP was measured and the baseline of the ECG 
(standard lead II) was printed over 5 seconds. The print was 
set up as 1.0 mV/cm and 25 mm/s. There was no delay in the 
Table 1.  Demographic Data and the Level of Sensory Block
Group S
(n = 20)
Group L
(n = 20)
Group E5
(n = 20)
Group E10
(n = 20)
P
Age (yr)
Sex (M/F)
Height (cm)
Weight (kg)
Cold test (block level)
Pin-prick test (block level)
  45.8 ± 15.5
8/12
162.0 ± 9.5
65.3 ± 9.4
   6.0 (3.95, 8)
8.0 (4, 10)
44.9 ± 14.4
12/8
165.2 ± 9.9
67.7 ± 9.5
6.0 (3.95, 8.05)
8.0 (4.95, 10.05)
44.6 ± 14.5
10/10
164.3 ± 11.8
65.4 ± 8.7
6.0 (4, 9)
        8.0 (6, 10.05)
40.4 ± 15.7
12/8
168.3 ± 8.6
67.9 ± 11.0
   6.5 (4.95, 9.05)
9.0 (6, 10.05)
0.660
0.271
0.742
0.151
0.356
Values are mean ± SD or number. Values of cold test and pin-prick test are median (5
th percentile, 95
th percentile). Group S: received 3 ml of nor-
mal saline, group L: received 3 ml of 1.0% lidocaine, group E5: received 3 ml of 1.0% lidocaine with epinephrine 5 μg, group E10: received 3 ml 
of 1.0% lidocaine with epinephrine 10 μg. 353 www.ekja.org
Korean J Anesthesiol Lee, et al.
monitoring waveform and printing waveform on the monitor. 
A simulated IV test dose was administered for 5 seconds and 
the ECG was printed over 5 seconds every 20 seconds for the 
first 2 minutes and at 5 minutes after administering the IV test 
dose. The size of the T-wave amplitude was measured from the 
average of three consecutive values based on the amplitudes 
shown in each printed ECG. In addition, the heart rate was 
measured from the average of two R-R intervals collected from 
three consecutive values. The heart rate measured at 3 and 4 
minutes were the values on the monitor. The SBP was measured 
every minute for 5 minutes. In addition, the subjective 
symptoms of the patients were divided into the symptoms of 
the central nervous system, such as dizziness, nervousness, 
and light-headedness and the symptoms of the cardiovascular 
system including palpitations, chest discomfort, and hot flushes. 
A positive response to the IV test dose was defined as a ≥20 
bpm increase in heart rate or a ≥15 mmHg increase in SBP or a 
≥25% decrease in T-wave amplitude. The sensitivity, specificity, 
positive predictive value (PPV) and negative predictive value 
(NPV) were calculated from results of the response. 
    The data is reported as the mean ± SD, but cold test and pin-
prick test were indicated as the median (5
th percentile, 95
th 
percentile). Statistical analysis was performed using software 
SigmaStat (version 3.0, Jandel Scientific Software). The data 
was compared using one way ANOVA between the groups and 
one way repeated measured ANOVA for within a group. If there 
were any differences, the data was compared using the Holm-
Sidak method for multiple comparisons. A P value < 0.05 was 
considered significant.
Results
    There were no differences in the baseline HR, SBP, and T-wave 
amplitude before administering the IV test dose between the 
groups (Table 2). In groups S and L, there was no change in the 
HR, SBP, and T-wave amplitude before and after administering 
the IV test dose. There was no significant difference between the 
two groups (Fig. 1, 2 and 3).
    The IV test dose caused an increase in HR at 20-80 seconds 
intervals in groups E5 and E10. The maximum increases 
in groups E5 and E10 were 30 ± 15 bpm and 28 ± 10 bpm, 
respectively. There was no significant difference in the changes 
in HR between groups E5 and E10 (P = 0.077, Fig. 1). In addition, 
the SBP were increased at 2-3 min intervals after the IV test dose 
in groups E5 and E10. The maximum increases in groups E5 and 
E10 were 19 ± 12 mmHg and 28 ± 16 mmHg, respectively. There 
was no significant difference in the changes in SBP between 
groups E5 and E10 (P = 0.313, Fig. 2). The T-wave amplitude was 
decreased at 20-80 seconds intervals in groups E5 and E10. 
The maximum decreases were 0.29 ± 0.20 mV and 0.32 ± 0.24 
Table 2. Baseline Values before Simulated Test Dose and the Maximum Change after Simulated Test Dose
Group S
(n = 20)
Group L
(n = 20)
Group E5
(n = 20)
Group E10
(n = 20)
P
HR (bpm)
    At baseline
    Maximum change
SBP (mmHg)
    At baseline
    Maximum change
T-wave Amp (mV)
    At baseline
    Maximum change
66 ± 14
67 ± 14
119 ± 12
121 ± 13
0.45 ± 0.33
0.42 ± 0.30
64 ± 12
66 ± 13
125 ± 18
127 ± 19
0.45 ± 0.26
0.40 ± 0.24
64 ± 9
        94 ± 17*,†
128 ± 15
      147 ± 19*,†
0.48 ± 0.33
      0.19 ± 0.16*,†
62 ± 12
      90 ± 12*,†
126 ± 18
      154 ± 25*,†
0.50 ± 0.23
      0.18 ± 0.21*,†
0.789
<0.001
0.342
<0.001
0.926
<0.001
Values are mean ± SD. HR: heart rate, SBP: systolic blood pressure. Group S: received 3 ml of normal saline, group L: received 3 ml of 1.0% lido-
caine, group E5: received 3 ml of 1.0% lidocaine with epinephrine 5 μg, group E10: received 3 ml of 1.0% lidocaine with epinephrine 10 μg. Base-
line values were no significant differences among the groups. *P < 0.05 compare with baseline value, 
†P < 0.05 compare with group S and group L.
Fig. 1. The changes of heart rate after simulated test dose intravenous 
administration. Values are mean ± SD. Group S: received 3 ml of 
normal saline, group L: received 3 ml of 1.0% lidocaine, group E5: 
received 3 ml of 1.0% lidocaine with epinephrine 5 μg, group E10: 
received 3 ml of 1.0% lidocaine with epinephrine 10 μg. *P < 0.05 
compare with baseline values in the group E5, 
†P < 0.05 compare 
with baseline values in the group E10.354 www.ekja.org
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mV respectively. The rate of the decrease was 66 ± 24% and 64 ± 
34% respectively. There was no significant difference between 
groups E5 and E10 (Fig. 3).
    Sixteen patients each in groups E5 and E10 showed a ≥20 
bpm increase in HR to the IV test doses. None of the patients 
in groups S and L showed a ≥20 bpm increase in HR. Eleven 
and 16 patients in groups E5 and E10, respectively, showed a 
≥15 mmHg increase in SBP. None of the patients in groups S 
and L showed a ≥15 mmHg increase in SBP. Twenty, 19, 1 and 
2 patients in groups E5, E10, S and L respectively, showed a 
≥25% decrease in baseline T-wave amplitude. Table 3 lists the 
sensitivity, specificity, PPV, and NPV for the changes in the HR, 
SBP, and T-wave amplitude. 
    Three and 4 patients in groups E5 and E10, respectively, com-
plained of central nervous symptoms. Eight and 7 patients in 
groups E5 and E10, respectively, complained cardiovascular 
sym  ptoms. The most common symptom was chest discomfort 
followed by palpitations, dizziness, and nerve uneasiness (Table 4).
Fig. 2. The changes of systolic blood pressure after simulated test 
dose intravenous administration. Values are mean ± SD. Group 
S: received 3 ml of normal saline, group L: received 3 ml of 1.0% 
lidocaine, group E5: received 3 ml of 1.0% lidocaine with epinephrine 
5 μg, group E10: received 3 ml of 1.0% lidocaine with epinephrine 10 
μg. *P < 0.05 compare with baseline values in the group E5, 
†P < 0.05 
compare with baseline values in the group E10.
Fig. 3. The percentage changes of T-wave amplitude after simulated 
test dose intravenous administration. Values are mean ± SD. Group 
S: received 3 ml of normal saline, group L: received 3 ml of 1.0% 
lidocaine, group E5: received 3 ml of 1.0% lidocaine with epinephrine 
5 μg, group E10: received 3 ml of 1.0% lidocaine with epinephrine 10 
μg. *P < 0.05 compare with baseline values in the group E5, 
†P < 0.05 
compare with baseline values in the group E10.
Table 3. Sensitivity, Specificity, and Positive and Negative Predictive 
Values Based on The Changes of Heart Rate, Systolic Blood Pressure, 
and T-wave Amplitude for Lidocaine Group
Group E5 
(n = 20)
Group E10 
(n = 20)
By HR (≥ 20 bpm increase)
    Sensitivity
    Specificity
    Positive predictive value
    Negative predictive value
By SBP (≥15 mmHg increase)
    Sensitivity
    Specificity
    Positive predictive value
    Negative predictive value
By T-wave amplitude (≥ 25% decrease)
    Sensitivity
    Specificity
    Positive predictive value
    Negative predictive value
By combination of T-wave amplitude and HR
    Sensitivity
    Specificity
    Positive predictive value
    Negative predictive value
By combination of T-wave amplitude and SBP
    Sensitivity
    Specificity
    Positive predictive value
    Negative predictive value
  80%
100%
100%
  83%
  55%
100%
100%
  70%
100%
  90%
  91%
100%
100%
  90%
  91%
100%
100%
  90%
  91%
100%
  80%
100%
100%
  83%
  80%
100%
100%
  83%
  95% 
  90%
  90%
  95%
100%
  90%
  91%
100%
100%
  90%
  91%
100%
HR: heart rate, SBP: systolic blood pressure. Group E5: received 3 ml 
of 1.0% lidocaine with epinephrine 5 μg, group E10: received 3 ml of 
1.0% lidocaine with epinephrine 10 μg.
Table 4.  Adverse Effects after Simulated Test Dose Intravenous Ad-
ministration
CNS symptoms C-V symptoms
Group S (n = 20)
Group L (n= 20)
Group E5 (n = 20)
Group E10 (n = 20)
0
0
3
4
0
0
  7*
  8*
Values are numbers of patient. CNS symptoms: dizziness, nervous-
ness, and vacantness, C-V symptoms: palpitation, chest discomfort, 
and facial flushing. Group S: received 3 ml of normal saline, group 
L: received 3 ml of 1.0% lidocaine, group E5: received 3 ml of 1.0% 
lidocaine with epinephrine 5 μg, group E10: received 3 ml of 1.0% 
lidocaine with epinephrine 10 μg. *P < 0.05 compare with group S.355 www.ekja.org
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Discussion 
    These results showed that the index of the T-wave amplitude 
on ECG can be used to detect the incidental IV injection of a 
simulated test dose containing low dose epinephrine in spinal 
anesthesia.
    The hemodynamic response of the epinephrine-containing 
test dose can be affected by several factors. The factors that may 
inhibit the increase in heart rate were aging [9], β-blockers [10], 
general anesthesia with using sevoflurane [11], and sedation 
using midazolam and fentanyl [12]. However, the increase in 
systolic blood pressure may be not suppressed. In the case of 
general anesthesia with isoflurane, the increase in heart rate 
and blood pressure can be suppressed [13, 14].
    Based on these results, an index of a ≥25% decrease in T-wave 
amplitude was more useful and superior to the hemodynamic 
index. Although the sensitivity, specificity and positive and 
negative predictive values of the hemodynamic index were 
55-100%, the index of the T-wave amplitude in groups E5 
and E10 was 90-100%. Only one patient in group E10 among 
epinephrine-injected groups showed a ≤25% decrease in the 
T-wave amplitude. This patient had a positive hemodynamic 
index. Therefore, it is believed that we can evaluate the IV 
injection of the test dose more accurately if the index of a 
T-wave decrease is used together with the hemodynamic index.
    The mechanism of the decrease in T-wave amplitude by epine-
phrine is unclear. However, it appears to occur by hypokalemia 
or the activation of β-adrenaline receptors [15-17]. Stimulation 
of the sympathetic nervous system causes an increase in the 
secretion of endogenous catecholamine, which causes a change 
in the T-wave amplitude [18-20]. 
    Hypokalemia can be caused by the influx of plasma potassium 
into a cell after stimulation of the β-adrenaline receptors by 
epinephrine. However, the period of administering epinephrine 
in this experiment was shortened to 5 seconds and the T-wave 
amplitude was changed temporarily. Therefore, the change of 
T-wave amplitude may not be due to hypokalemia but to the 
stimul  ation of β-adrenaline receptors within the heart.
    There was one patient in the saline group and 2 patients in 
the lidocaine group who showed a ≥25% decrease of T-wave 
amplitude, which has not been reported. Normally, the T-wave 
amplitude is decreased by epinephrine and recovered along 
with a regular pattern. However, there were irregular patterns of 
the T-wave showed in 3 patients in each measuring moments. 
In the case when the amplitude of the T-wave is <0.3 mV, it 
appears to decrease more than 25% even though it is only 
decreased slightly. Therefore, it is believed that the regular pattern 
of change will be more important than the size of the T-wave 
amplitude.
    There were some limitations in the index of the T-wave 
amplitude. It is difficult to measure the change in the T-wave 
size in the case of showing an abnormal T-wave or small T-wave. 
In addition, it can be difficult to evaluate visually because most 
of the normal T-waves are <0.5 mV and the ECG can be altered 
by movement due to breathing [7]. Therefore, the T-wave needs 
to be observed by increasing the scale of ECG, and by printing 
and calculating the changes in ECG in order to apply the T-wave 
index. More study on the change in T-wave with monitoring 
instead of the printed ECG will be needed. In addition, unlike 
anesthesia in adults, the change in the T-wave of children is not 
useful as a marker for accidental intravascular injection [5].
    Three and 4 patients in groups E5 and E10, respectively, 
complained of dizziness, nervousness, and light-headedness 
caused by the administration of epinephrine. Seven and 8 
patients in groups E5 and E10, respectively, complained of 
palpitations, chest discomfort, and hot flush. In addition, 6 
and 5 patients in groups E5 and E10, respectively, showed an 
increase in the maximum instantaneous heart rate by more 
than 100 bpm. In particular, there was one patient who had a 
>130 bpm increase. There were 3 patients in group E10 who 
showed an increase in systolic blood pressure to more than 180 
mmHg. However, all of the changes in the index were recovered 
within 3 minutes. The symptoms of the central nerve system 
and cardiovascular system were also temporary.
    There was no statistical difference in the index of decreasing 
T-wave amplitude between E5 and E10. Therefore, the T-wave 
amplitude can be changed with <5 μg of epinephrine used 
in the epidural test dose. However, it is believed that it will be 
difficult to apply in a clinical setting. It was assumed that the 
entire epidural test dose through the epidural catheter had been 
administered into blood vessels without any loss. However, 
it is unclear if the full epidural test dose is administered into 
blood vessel through an epidural catheter in a real situation. 
Like in this case, only epinephrine 5 μg as the epidural test 
dose cannot be sufficient to cause a change in the T-wave after 
the unintentional IV administration of epinephrine. Therefore, 
further studies will be needed to prove the efficacy of the 
T-wave amplitude in cases of <5 μg of epinephrine because the 
decrease in T-wave size in this study was not proportional to the 
dose of epinephrine.
    In conclusion, the change in T-wave in spinal anesthesia may 
be clinically useful to detect an unintentional intravascular 
injection of low dose epinephrine containing an epidural 
test dose in CSEA. However, further studies will be needed to 
determine the suitable test dose of epinephrine.
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